LiqTech International announces pricing Of Public Offering of Common
Stock
23/07/2014 17:56
LiqTech International, Inc., a clean technology company that manufactures and markets highly specialized filtration technologies, today announced that it has priced a registered firm commitment underwritten public offering of 6,956,522 shares of its common stock at a price to the public of USD 1.50. In addition, LiqTech has granted the underwriter a 30-day option to purchase up to 1,043,478 additional shares of common stock to cover over-allotments, if any. The offering is expected to close on or about July 28, 2014, subject to satisfaction of closing conditions. The total gross proceeds of the offering are expected to be approximately USD 10.4 million. After deducting the underwriter's discount and other estimated offering expenses payable by LiqTech, the net proceeds are expected to be approximately USD 9.4 million. These amounts assume no exercise of the underwriter's over-allotment option. The Company intends to use the net proceeds of the offering to fund a portion of the purchase price for its previously announced acquisition of the operations of Provital Solutions A/S. If the acquisition is not completed, LiqTech intends to use the net proceeds from this offering to pay transaction expenses, and for other general corporate purposes.
23/07/2014 17:56
LiqTech International, Inc., a clean technology company that manufactures and markets highly specialized filtration technologies, today announced that it has priced a registered firm commitment underwritten public offering of 6,956,522 shares of its common stock at a price to the public of USD 1.50. In addition, LiqTech has granted the underwriter a 30-day option to purchase up to 1,043,478 additional shares of common stock to cover over-allotments, if any. The offering is expected to close on or about July 28, 2014, subject to satisfaction of closing conditions. The total gross proceeds of the offering are expected to be approximately USD 10.4 million. After deducting the underwriter's discount and other estimated offering expenses payable by LiqTech, the net proceeds are expected to be approximately USD 9.4 million. These amounts assume no exercise of the underwriter's over-allotment option. The Company intends to use the net proceeds of the offering to fund a portion of the purchase price for its previously announced acquisition of the operations of Provital Solutions A/S. If the acquisition is not completed, LiqTech intends to use the net proceeds from this offering to pay transaction expenses, and for other general corporate purposes.
